Tofadoz Tablet (Tofacitinib)
Tofadoz Tablet contains Tofacitinib, a Janus kinase (JAK) inhibitor used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It helps reduce inflammation, joint pain, and swelling by modulating the immune response.
Introduction
Tofadoz Tablet contains Tofacitinib, a Janus kinase (JAK) inhibitor prescribed to manage autoimmune and inflammatory conditions. This medication is designed for adults suffering from moderate to severe rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis, especially those who haven’t responded well to conventional treatments. It helps reduce pain, swelling, and inflammation, improving overall quality of life.
Precautions of Tofadoz Tablet (Tofacitinib)
Who should take Tofadoz:
- Adults diagnosed with RA, PsA, or UC
- Patients with inadequate response to other DMARDs or biologics
Who should avoid Tofadoz:
- Individuals with active or chronic infections (e.g., tuberculosis, hepatitis)
- Patients with severe liver disease
- Pregnant or breastfeeding women (unless advised by a doctor)
- Those with a history of blood clots or cardiovascular risks
Uses of Tofadoz Tablet (Tofacitinib)
Tofadoz Tablet is primarily used to treat the following conditions:
- Rheumatoid arthritis (RA)
- Psoriatic arthritis (PsA)
- Ulcerative colitis (UC)
- Juvenile idiopathic arthritis (in eligible pediatric patients, when advised)
- Other off-label autoimmune or inflammatory conditions as determined by a healthcare provider.
Side Effects of Tofadoz Tablet (Tofacitinib)
While Tofadoz is effective, it may cause some side effects. Common and serious effects include:
Common side effects:
- Headache
- Diarrhea
- Nasal congestion or sore throat
- High blood pressure
- Increased cholesterol levels
- Serious side effects (seek immediate medical attention):
Increased risk of serious infections (e.g., tuberculosis)
- Liver enzyme abnormalities
- Blood clots
- Increased risk of certain cancers (long-term use)
- Gastrointestinal perforations
Always report any unusual symptoms to your healthcare provider promptly.
FAQs of Tofadoz Tablet (Tofacitinib)
Q1: How long does it take for Tofadoz to show results?
A: Some patients begin noticing improvement in symptoms within a few weeks, though full benefits may take up to 3 months.
Q2: Can I stop taking Tofadoz once I feel better?
A: No, always follow your doctor’s instructions. Stopping suddenly can lead to a flare-up of symptoms.
Q3: Is Tofadoz safe for long-term use?
A: Yes, but regular monitoring is essential due to risks like infections, blood clots, or liver issues.
Q4: Can Tofadoz be taken with food?
A: Yes, Tofadoz can be taken with or without food. Follow the prescribed schedule for best results.
Interactions of Tofadoz Tablet (Tofacitinib)
Tofadoz may interact with the following:
- Other immunosuppressants (e.g., biologics like Adalimumab or Etanercept) – may increase risk of infections
- Strong CYP3A4 inhibitors or inducers (e.g., ketoconazole, rifampin) – may affect drug levels
- Live vaccines – avoid during treatment
- Anticoagulants or antiplatelet drugs – may increase bleeding risk
Always inform your doctor about all current medications and supplements.
| Manufacturer | : | MSN Laboratories |
| Trade Name | : | |
| Generic Search | : | Tofacitinib |
| Strength | : | 5 mg,10mg,11mg |
Latest Products
